
CVS Health Corp is seeking to buy Signify Health Inc as it looks to expand in-home health services, the Wall Street Journal reported on Sunday, citing sources.
Signify Health is working with bankers to explore strategic alternatives, including a sale, the Journal reported last week.
Initial bids are due this coming week, and CVS is planning to enter one, the report said. Signify has a market cap of around $4.66 billion based on its stock closing price on Friday, according to Refinitiv calculations.
CVS, which runs drugstores and provides health insurance, is among the companies seeking to submit initial bids this week, the Wall Street Journal wrote Sunday. The Journal reported last week that Signify, which had a stock-market capitalization of $4.66 billion as of Friday, was exploring strategic alternatives including a possible sale.
Through its software and services, Signify aims to help clients — payers like health plans, government programs and employers — shift to value-based payment plans. These arrangements are intended to improve care and reduce spending by treating patients in lower-cost settings and linking providers’ payments to patient outcomes. An acquisition may align with CVS Chief Executive Officer Karen Lynch’s move toward more interaction with patients, including primary care locations in its chain of drugstores.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas